EBS News and Press, Emergent Biosolutions Inc. From 10/29/25

2025-10-29 20:57:24 ET More on Emergent Biosolutions Emergent BioSolutions Inc. (EBS) Q3 2025 Earnings Call Transcript Emergent BioSolutions: Q2 Results Could Spark A Strong 2025 Rally Emergent BioSolutions Inc. (EBS) Q2 2025 Earnings Call Transcript Emergent...

2025-10-29 20:56:30 ET Emergent BioSolutions Inc. (EBS) Q3 2025 Earnings Call October 29, 2025 5:00 PM EDT... Read the full article on Seeking Alpha For further details see: Emergent BioSolutions Inc. (EBS) Q3 2025 Earnings Call Transcript

2025-10-29 16:26:07 ET More on Emergent Biosolutions Emergent BioSolutions: Q2 Results Could Spark A Strong 2025 Rally Emergent BioSolutions Inc. (EBS) Q2 2025 Earnings Call Transcript Emergent Biosolutions Q3 2025 Earnings Preview Emergent Biosolutions secur...

Third Quarter 2025 Total Revenues of $231.1 million, above the high end of Q3 guidance by $21.0 million Third Quarter 2025 Net Income of $51.2 million and Net Income Margin of 22% Third Quarter 2025 Gross Margin % of 54% and Adjusted Gross Margin % of 61%, an expansion of 300 bps and 200 ...

Amerigo Resources Ltd (ARREF) is expected to report $0.06 for Q3 2025 Bausch + Lomb Corporation (BLCO) is expected to report $0.16 for Q3 2025 Hayward Holdings Inc. (HAYW) is expected to report $0.11 for Q3 2025 Automatic Data Processing Inc. (ADP) is expected to report $2.44 for Q1 2...

GAITHERSBURG, Md., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced the results of a new survey 1 of approximately 250 U.S. policy opinion leaders showing that nearly two-thirds (65 percent) of respondents agree the likelihood of a biological attack on ...

GAITHERSBURG, Md., Oct. 08, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Wednesday, October 29, 2025, at 5:00 pm eastern time to discuss the financial results for the third quarter of 2025. Participants can access the conference call live via ...

GAITHERSBURG, Md., Sept. 24, 2025 (GLOBE NEWSWIRE) -- In recognition of several observances in September meant to keep the national opioid poisoning epidemic front and center, Emergent BioSolutions Inc. (NYSE: EBS) today recommitted to its leadership combating the opioid crisis through a multi-fa...

2025-09-19 08:39:09 ET More on Emergent Biosolutions Emergent BioSolutions: Q2 Results Could Spark A Strong 2025 Rally Emergent BioSolutions secures $17M contract modification for oral suspension TEMBEXA Mpox in Africa is no longer a global health emergency, WHO chie...

GAITHERSBURG, Md., Sept. 19, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced it has secured new purchase orders from an international government partner for a multi-product supply agreement valued at $29 million (USD). The orders span several product offerings with...